Cargando…

Yield of Clinical Screening for Hypertrophic Cardiomyopathy in Child First-Degree Relatives: Evidence for a Change in Paradigm

BACKGROUND: Hypertrophic cardiomyopathy (HCM) is a heritable myocardial disease with age-related penetrance. Current guidelines recommend clinical screening of relatives beginning at 10 years of age, but the clinical value of this approach has not been systematically evaluated. METHODS: Anonymized c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Norrish, Gabrielle, Jager, Joanna, Field, Ella, Quinn, Ellie, Fell, Hannah, Lord, Emma, Cicerchia, Marcos N., Ochoa, Juan Pablo, Cervi, Elena, Elliott, Perry M., Kaski, Juan Pablo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2019
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636798/ https://www.ncbi.nlm.nih.gov/pubmed/31006259 http://dx.doi.org/10.1161/CIRCULATIONAHA.118.038846

Ejemplares similares

Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers
por: Lorenzini, Massimiliano, et al.
Publicado: (2020)

Outcomes following general anaesthesia in children with hypertrophic cardiomyopathy
por: Norrish, Gabrielle, et al.
Publicado: (2019)

Childhood Hypertrophic Cardiomyopathy: A Disease of the Cardiac Sarcomere
por: Norrish, Gabrielle, et al.
Publicado: (2021)

Risk stratification in childhood hypertrophic cardiomyopathy
por: Norrish, Gabrielle, et al.
Publicado: (2018)

Performance of the PRIMaCY sudden death risk prediction model for childhood hypertrophic cardiomyopathy: implications for implantable cardioverter-defibrillator decision-making
por: Norrish, Gabrielle, et al.
Publicado: (2023)

Friedreich’s ataxia-associated childhood hypertrophic cardiomyopathy: a national cohort study
por: Norrish, Gabrielle, et al.
Publicado: (2022)

Clinical and Genetic Screening for Hypertrophic Cardiomyopathy in Paediatric Relatives: Changing Paradigms in Clinical Practice
por: Lawley, Claire M., et al.
Publicado: (2023)

Becker muscular dystrophy associated with sarcomeric hypertrophic cardiomyopathy in a paediatric patient: a case report
por: Dolader, Paola, et al.
Publicado: (2019)

Noncompaction Cardiomyopathy, Sick Sinus Disease, and Aortic Dilatation: Too Much for a Single Diagnosis?
por: Brunet-Garcia, Laia, et al.
Publicado: (2022)

Clinical presentation and survival of childhood hypertrophic cardiomyopathy: a retrospective study in United Kingdom
por: Norrish, Gabrielle, et al.
Publicado: (2019)

External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy
por: Norrish, Gabrielle, et al.
Publicado: (2021)

A validation study of the European Society of Cardiology guidelines for risk stratification of sudden cardiac death in childhood hypertrophic cardiomyopathy
por: Norrish, Gabrielle, et al.
Publicado: (2019)

Clinical presentation and long‐term outcomes of infantile hypertrophic cardiomyopathy: a European multicentre study
por: Norrish, Gabrielle, et al.
Publicado: (2021)

The genetics of hypertrophic cardiomyopathy
por: Akhtar, Mohammed, et al.
Publicado: (2018)

Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic Cardiomyopathy
por: Norrish, Gabrielle, et al.
Publicado: (2022)

Phenotypes of hypertrophic cardiomyopathy. An illustrative review of MRI findings
por: Soler, Rafaela, et al.
Publicado: (2018)

The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy
por: Norrish, Gabrielle, et al.
Publicado: (2021)

Mutations in TRIM63 cause an autosomal-recessive form of hypertrophic cardiomyopathy
por: Salazar-Mendiguchía, Joel, et al.
Publicado: (2020)

Cardiac Manifestations of Myotonic Dystrophy in a Pediatric Cohort
por: Brunet Garcia, Laia, et al.
Publicado: (2022)

Analysis of buccal mucosa as a prognostic tool in children with arrhythmogenic cardiomyopathy
por: Bueno-Beti, Carlos, et al.
Publicado: (2022)

Myocardial Perfusion Defects in Hypertrophic Cardiomyopathy Mutation Carriers
por: Hughes, Rebecca K., et al.
Publicado: (2021)

Relationship Between Maximal Left Ventricular Wall Thickness and Sudden Cardiac Death in Childhood Onset Hypertrophic Cardiomyopathy
por: Norrish, Gabrielle, et al.
Publicado: (2022)

Editorial: Paediatric Cardiomyopathies
por: Monda, Emanuele, et al.
Publicado: (2021)

Editorial: Cardiovascular genetics—focus on paediatric cardiomyopathy
por: Monda, Emanuele, et al.
Publicado: (2023)

Prognostic Implication of First‐Degree Atrioventricular Block in Patients With Hypertrophic Cardiomyopathy
por: Higuchi, Satoshi, et al.
Publicado: (2020)

Prediction of thrombo‐embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk‐CVA)
por: Guttmann, Oliver P., et al.
Publicado: (2015)

Heart Rate Recovery in Patients With Hypertrophic Cardiomyopathy
por: Patel, Vimal, et al.
Publicado: (2014)

Prevalence of Hypertrophic Cardiomyopathy in the UK Biobank Population
por: Lopes, Luis R., et al.
Publicado: (2021)

Alcohol septal ablation in hypertrophic cardiomyopathy
por: Mateo, Juan José Santos, et al.
Publicado: (2018)

The embryological basis of subclinical hypertrophic cardiomyopathy
por: Captur, Gabriella, et al.
Publicado: (2016)

Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy
por: Braunwald, Eugene, et al.
Publicado: (2023)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

Stress cardiomyopathy in a patient with hypertrophic cardiomyopathy and myocardial bridging
por: Benavides, Miguel, et al.
Publicado: (2017)

Identification of an elusive spliceogenic MYBPC3 variant in an otherwise genotype-negative hypertrophic cardiomyopathy pedigree
por: Torrado, Mario, et al.
Publicado: (2022)

First‐Degree Atrioventricular Block and Hypertrophic Cardiomyopathy: “I Have a Bad Feeling About This”
por: Wong, Timothy C.
Publicado: (2020)

Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing
por: Lopes, Luis R, et al.
Publicado: (2013)

The use of multiparametric CMR to predict impaired exercise capacity in hypertrophic cardiomyopathy
por: Flett, Andrew S, et al.
Publicado: (2009)

Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy
por: Lopes, Luis R, et al.
Publicado: (2021)

The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy
por: Kittleson, Mark D, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sedkr8j7uu7bqnaot1u5tk2gka